News IT Zydus Cadila's shares have jumped over 4% to close at over ₹570 a piece on Friday. Cadila said in its Phase III clinical trials, the therapy had shown better clinical improvement in the patients suffering from COVID-19. visit on varindia site to know more about it News IT, Best IT Magazine In India, Latest Technolog...